Immunogens from uropathogenic
Disclosed herein are various genes that can be included in immunogenic compositions specific for pathogenic E. coli strains. The genes are from uropathogenic strains but are absent from non-pathogenic strains, and their encoded proteins have cellular locations which render them accessible to the immune system.
1. A method for raising an immune response in a subject, comprising the step of administering to the subject a pharmaceutical composition comprising a pharmaceutically acceptable carrier in admixture with (a) an amino acid sequence that is the full-length amino acid sequence set forth in SEQ ID NO: 577; (b) an amino acid sequence that is at least 90% identical to the full-length amino acid sequence set forth in SEQ ID NO: 577; (c) an amino acid sequence which is a fragment of at least 10 consecutive amino acids from SEQ ID NO: 577; or (d) an amino acid sequence that is at least 90% identical to the full-length amino acid sequence set forth in SEQ ID NO: 577 and includes a fragment of at least 10 consecutive amino acids from SEQ ID NO: 577.
2. The method of claim 1 , wherein the pharmaceutical composition further comprises an adjuvant.
3. The method of claim 1 , wherein the pharmaceutically acceptable carrier is in admixture with (b).
4. The method of claim 3 , wherein the amino acid sequence is at least 95% identical to the full-length amino acid sequence set forth in SEQ ID NO: 577.
5. The method of claim 1 , wherein the pharmaceutically acceptable carrier is in admixture with (c).
6. The method of claim 5 , wherein the amino acid sequence is a fragment of at least 16 consecutive amino acids from SEQ ID NO: 577.
7. The method of claim 1 , wherein the pharmaceutically acceptable carrier is in admixture with (d).
8. The method of claim 7 , wherein the amino acid sequence is at least 95% identical to the full-length amino acid sequence set forth in SEQ ID NO: 577 and includes a fragment of at least 16 consecutive amino acids from SEQ ID NO: 577.